总时间（秒）：14.37
问答时间（秒）：12.27

Here is the JSON output based on the provided literature:

```
{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_032799.4:c.Ser910Ala (p.Ser3100Ala)",
          "cDNA Change": {
            "transcript": "NM_032799.4",
            "ref": "Ser910",
            "alt": "Ala",
            "position": "3100"
          },
          "Protein Change": {
            "ref": "Ser910",
            "alt": "Ala",
            "position": "3100"
          },
          "Description in input context": "phosphorylation of Ser910 and Ser935 is disrupted by multiple Parkinson’s disease-associated mutations."
        },
        {
          "HGVS": "NM_032799.4:c.Ser935Thr (p.Ser3155Thr)",
          "cDNA Change": {
            "transcript": "NM_032799.4",
            "ref": "Ser935",
            "alt": "Thr",
            "position": "3155"
          },
          "Protein Change": {
            "ref": "Ser935",
            "alt": "Thr",
            "position": "3155"
          },
          "Description in input context": "phosphorylation of Ser910 and Ser935 is disrupted by multiple Parkinson’s disease-associated mutations."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson’s disease",
    "MONDO": "MONDO:0005508"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot, Immunoprecipitation, and Microscopy",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Swiss 3T3 cells",
        "Description": "The experiment was conducted using Swiss 3T3 cells."
      },
      "Readout type": "Quantitative, Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032799.4:c.Ser910Ala (p.Ser3100Ala)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The variant NM_032799.4:c.Ser910Ala (p.Ser3100Ala) accumulated within discrete cytoplasmic pools, resembling inclusion bodies."
        },
        {
          "Variant": "NM_032799.4:c.Ser935Thr (p.Ser3155Thr)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The variant NM_032799.4:c.Ser935Thr (p.Ser3155Thr) accumulated within discrete cytoplasmic pools, resembling inclusion bodies."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "5"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```

Note that some fields may have been left blank or with a default value of N.D. (not described in the literature), as not all information was explicitly mentioned in the provided text.